Expected to Improve Conversion Efficiency and Profitability
ATLANTA, GA , Jan. 16, 2018 (GLOBE NEWSWIRE) -- Meridian Waste Solutions, Inc. (NASDAQ: MRDN) (“Meridian” or the “Company”), an integrated, non-hazardous solid waste services and innovative technology company, today announced the execution by the Company’s subsidiary, Attis Innovations, Inc., of a license agreement for proprietary biofuel process technology proven with initial testing to provide for significant improvements in conversion efficiency.
Biodiesel is one of the most abundant biofuels produced today, contributing more than 2 billion gallons in 2016 to the United States Renewable Fuel Standard. It is a renewable, clean-burning replacement for fossil fuels that is made from a diverse mix of virgin and waste feedstocks, including animal fats, vegetable oils, greases and other lipids. Existing biodiesel production methods require the use of multiple catalyst and purification steps that have innate inefficiencies that the Attis engineering team has targeted for reduction.
The new license involves technology designed to achieve that objective by eliminating process steps that reduce raw material consumption while increasing feedstock tolerances, and improving both product yield and quality. Subject to further verification and scale-up testing, the new approach is expected to reduce construction costs and improve profitability by an estimated $0.40 per gallon.
Importantly, the Company also expects to integrate the new technology into its growing ecosystem of biomass conversion and refining technologies, including Attis’ patented and patent-pending AST-Organosolv process, which fractionates and converts cellulosic biomass into ethanol or butanol and a renewable alternative for petroleum-derived resins.
“We believe that the solid waste industry has overlooked compelling opportunities to extract significant value from large volumes of carbonaceous wastes and other by-products produced by several industries,” said Jeff Cosman, Meridian’s Chief Executive Officer. “We plan to harvest those opportunities to generate increased shareholder value as part of the continuing evolution of our approach to waste management in 2018, as exemplified to date by our expanding relationship with key agencies, our $3 million grant award from the USDA, and recent and planned acquisitions. We’re pleased to include the new license in our portfolio.”
Additional information on Attis’ technologies is available online at www.attisinnovations.com and www.amsnt.com.
About Meridian Waste Solutions, Inc.
Meridian Waste Solutions, Inc. (NASDAQ: MRDN) is a company defined by our commitment to servicing our customers with unwavering respect, fairness and care. We are focused on finding and implementing solutions for the resource needs and challenges of our customers with a fundamental objective to seek rewarding environmental solutions through technology and innovation. Our core waste business is centered on residential and commercial waste collection and disposal. Currently, the company operates in St. Louis, Missouri and Richmond, Virginia servicing over 130,000 residential, commercial, industrial and governmental customers. In addition to a fleet of commercial, residential and roll off trucks, the Company operates three transfer stations, one recycling facility and three municipal solid waste landfills. The technology division centers on creating community-based synergies through healthcare collaborations and software solutions. Our innovation division (http://attisinnovations.com) strives to create value from recovered resources, through advanced byproduct technologies and assets found in downstream production. For more information, visit www.MWSinc.com.
Forward-Looking Statements
Any statements contained in this press release that do not describe historical facts may constitute forward-looking statements as that term is defined in the Private Securities Litigation Reform Act of 1995. Such forward-looking statements include, among other thing, statements regarding the offering, the expected gross proceeds, the expected use of proceeds and the expected closing of the offering. Any forward-looking statements contained herein are based on current expectations, but are subject to a number of risks and uncertainties. The factors that could cause actual future results to differ materially from current expectations include, but are not limited to, risks and uncertainties relating to the Company's ability to develop, market and sell products based on its technology; the expected benefits and efficacy of the Company's products and technology; the availability of substantial additional funding for the Company to continue its operations and to conduct research and development, clinical studies and future product commercialization; and, the Company's business, research, product development, regulatory approval, marketing and distribution plans and strategies. These and other factors are identified and described in more detail in our filings with the SEC, including, our current reports on Form 8-K.